1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Approvals

Abbott Gains CE Marks For New Tricuspid Device And Expanded Xience DES Indication

 
• By Reed Miller

The next-generation TriClip G4 comes in more sizes than the original TriClip and features enhanced leaflet grasping features.

Triclip transcatheter tricuspid repair device
TriClip G4 Transcatheter Tricuspid Repair Clip • Source: Abbott

Abbott announced two important CE marks, expanding access to the company’s TriClip minimally invasive tricuspid valve repair technology and its market-leading Xience everolimus-eluting coronary stent.

On 8 April, Abbott announced it received a CE mark for the TriClip G4, the next-generation version of its TriClip transcatheter tricuspid valve repair system. Health Canada licensed TriClip...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

FDA Draft Guidance Introduces Electric Submission For Q-Sub Process

 
• By Brian Bossetta

The US FDA says its updated draft guidance represents one of several steps the agency is taking to develop electronic submission templates for the medical device industry. The document introduces stakeholders to currently available resources for supporting their pre-subs to the agency.

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Commission’s Flora Giorgio Says Simplification And Safety Are Key In Evolving EU Regs

 
• By Amanda Maxwell

Predictability, proportionality, stability, harmonization and simplification offer the right way forward to address the challenging unintended effects of the EU medical device regulations, the European Commission’s head of devices tells the EU’s largest annual medtech conference.